Literature DB >> 1136841

Quantitative rating of depressive states.

P Bech, L F Gram, E Dein, O Jacobsen, J Vitger, T G Bolwig.   

Abstract

A step-by-step analysis of Beck's and Hamilton's rating scales showed that both scales failed to differentiate adequately between moderate and severe depression measured by a global clinical assessment. Each item of the scales was tested for calibration, ascending monotonicity, and dispersion parallel to the clinical assessment. Twelve items of Beck's scale and six items of Hamilton's scale were found valid with respect to these criteria. Those items should be taken into account in future research for baseline ratings and for change ratings of depressive states quantitatively.

Entities:  

Mesh:

Year:  1975        PMID: 1136841     DOI: 10.1111/j.1600-0447.1975.tb00002.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  83 in total

1.  Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression.

Authors:  Isabella Helmreich; Stefanie Wagner; Roland Mergl; Antje-Kathrin Allgaier; Martin Hautzinger; Verena Henkel; Ulrich Hegerl; André Tadić
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-09-30       Impact factor: 5.270

2.  A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder.

Authors:  Lobna Ibrahim; Nancy Diaz Granados; Libby Jolkovsky; Nancy Brutsche; David A Luckenbaugh; W Joseph Herring; William Z Potter; Carlos A Zarate
Journal:  J Clin Psychopharmacol       Date:  2012-08       Impact factor: 3.153

Review 3.  Social functioning: should it become an endpoint in trials of antidepressants?

Authors:  Per Bech
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale.

Authors:  Roger S McIntyre; Jakub Z Konarski; Deborah A Mancini; Kari A Fulton; Sagar V Parikh; Sophie Grigoriadis; Larry A Grupp; David Bakish; Marie-Josee Filteau; Chris Gorman; Charles B Nemeroff; Sidney H Kennedy
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

5.  Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants.

Authors:  P Bech; P Allerup; N Reisby; L F Gram
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account.

Authors:  Søren D Østergaard; Barnett S Meyers; Alastair J Flint; Benoit H Mulsant; Ellen M Whyte; Christine M Ulbricht; Per Bech; Anthony J Rothschild
Journal:  J Affect Disord       Date:  2014-01-02       Impact factor: 4.839

Review 7.  Severe depression: is there a best approach?

Authors:  S B Sonawalla; M Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

8.  A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.

Authors:  Charles H Bombardier; Jesse R Fann; Catherine S Wilson; Allen W Heinemann; J Scott Richards; Ann Marie Warren; Larry Brooks; Catherine A Warms; Nancy R Temkin; Denise G Tate
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

9.  Assessing full remission.

Authors:  Roger McIntyre; Sidney Kennedy; R Michael Bagby; David Bakish
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

10.  Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.

Authors:  Nader Perroud; Rudolf Uher; Andrej Marusic; Marcella Rietschel; Ole Mors; Neven Henigsberg; Joanna Hauser; Wolfgang Maier; Daniel Souery; Anna Placentino; Aleksandra Szczepankiewicz; Lisbeth Jorgensen; Jana Strohmaier; Astrid Zobel; Caterina Giovannini; Amanda Elkin; Cerisse Gunasinghe; Joanna Gray; Desmond Campbell; Bhanu Gupta; Anne E Farmer; Peter McGuffin; Katherine J Aitchison
Journal:  BMC Med       Date:  2009-10-15       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.